2001; 142(3):498-501 161. Joint Formulary Committee. British National Formulary. London. 2016. Available from: http://www.medicinescomplete.com 162. Jolicoeur EM, Dunning A, Castelvecchio S, Dabrowski R, Waclawiw MA, Petrie MC et al. Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. Journal of the American College of Cardiology. 163. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. Journal of the American College of Cardiology. 2007; 49(16):1733-9 164. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. New England Journal of Medicine. 2004; 351(6):543-51 Chronic Heart Failure Reference list NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: 978-1-4731-3093-7 165. Kanwar MK, Lohmueller LC, Kormos RL, Loghmanpour NA, Benza RL, Mentz RJ et al. Low accuracy of the HeartMate Risk Score for predicting mortality using the INTERMACS Registry data. ASAIO Journal. 2017; 63(3):251-256 166. Kao DP, Lewsey JD, Anand IS, Massie BM, Zile MR, Carson PE et al. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response. European Journal of Heart Failure. 2015; 167. Kao DP, Wagner BD, Robertson AD, Bristow MR, Lowes BD. A personalized BEST: characterization of latent clinical classes of nonischemic heart failure that predict outcomes and response to bucindolol. PloS One. 2012; 7(11):e48184 168. Karapolat H, Demir E, Bozkaya YT, Eyigor S, Nalbantgil S, Durmaz B et al. Comparison of hospital-based versus home-based exercise training in patients with heart failure: effects on functional capacity, quality of life, psychological symptoms, and hemodynamic parameters. Clinical Research in Cardiology. 2009; 98(10):635-42 169. 